Emergent BioSolutions' GAAP net income for 2020 was $305.1 million, up 5.6 times from $54.5 million in the previous year. Revenue increased 40.6% to $1.555 billion from $1.106 billion a year earlier.
Emergent BioSolutions' GAAP net income for 2020 was $305.1 million, up 5.6 times from $54.5 million in the previous year. Revenue increased 40.6% to $1.555 billion from $1.106 billion a year earlier. 
investors.emergentbiosolutions.com
English (US) 